{
    "startDate": "2022-01-01",
    "endDate": "2022-03-31",
    "year": "2022",
    "quarter": "Q1",
    "symbol": "VTVT",
    "data": {
        "bs": [
            {
                "label": "Long-term investments",
                "concept": "LongTermInvestments",
                "unit": "usd",
                "value": 5939000
            },
            {
                "label": "Operating lease liabilities, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 441000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 12138000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 12100000.0
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 12700000
            },
            {
                "label": "Current portion of operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 191000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 20185000
            },
            {
                "label": "Total stockholders\u2019 deficit attributable to vTv Therapeutics Inc.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -8093000
            },
            {
                "label": "Total stockholders\u2019 deficit attributable to vTv Therapeutics Inc.",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -8093000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 13911000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 12474000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1387000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 238669000
            },
            {
                "label": "Total liabilities, redeemable noncontrolling interest and stockholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 20185000
            },
            {
                "label": "Warrant liability, related party",
                "concept": "DueToRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 770000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -247663000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -247700000.0
            },
            {
                "label": "Redeemable noncontrolling interest",
                "concept": "RedeemableNoncontrollingInterestEquityCarryingAmount",
                "unit": "usd",
                "value": 14367000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 255000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 13612000
            },
            {
                "label": "Current deposits",
                "concept": "DepositsAssetsCurrent",
                "unit": "usd",
                "value": 30000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 57000
            },
            {
                "label": "Current portion of contract liabilities",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 35000
            },
            {
                "label": "Current portion of contract liabilities",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 35000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 379000
            }
        ],
        "cf": [
            {
                "label": "Change in redemption value of noncontrolling interest",
                "concept": "MinorityInterestChangeInRedemptionValue",
                "unit": "usd",
                "value": 8178000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -732000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -1021000
            },
            {
                "label": "Repayment of notes payable",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": 256000
            },
            {
                "label": "Net loss before noncontrolling interest",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -9424000
            },
            {
                "label": "Net loss before noncontrolling interest",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -9424000
            },
            {
                "label": "Net loss before noncontrolling interest",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -9424000
            },
            {
                "label": "Net (decrease) increase in cash, cash equivalents and restricted cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -1277000
            },
            {
                "label": "Change in fair value of investments",
                "concept": "UnrealizedGainLossOnInvestments",
                "unit": "usd",
                "value": -3234000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 476000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 4430000
            },
            {
                "label": "Net cash (used in) provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -256000
            },
            {
                "label": "Change in fair value of warrants, related party",
                "concept": "vtvt:ChangeInFairValueOfWarrantsRelatedParty",
                "unit": "usd",
                "value": -492000
            }
        ],
        "ic": [
            {
                "label": "Other expense",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -3234000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -6481000
            },
            {
                "label": "Net loss attributable to vTv Therapeutics Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -7007000
            },
            {
                "label": "Net loss attributable to vTv Therapeutics Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -7007000
            },
            {
                "label": "Loss before income taxes and noncontrolling interest",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -9224000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 8481000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 3133000
            },
            {
                "label": "Income tax provision",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Income tax provision",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 200000.0
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 5348000
            },
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 2000000
            },
            {
                "label": "Other income (expense) \u2013 related party",
                "concept": "vtvt:OtherIncomeExpensesRelatedParty",
                "unit": "usd",
                "value": 492000
            },
            {
                "label": "Net loss attributable to vTv Therapeutics Inc. common shareholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -7007000
            },
            {
                "label": "Net loss attributable to vTv Therapeutics Inc. common shareholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -7007000
            },
            {
                "label": "Less: net loss attributable to noncontrolling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -2417000
            },
            {
                "label": "Less: net loss attributable to noncontrolling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -2417000
            }
        ]
    }
}